QR Code

Real-World Effectiveness of Racotumomab as Maintenance Therapy in Advanced Non-Small Cell Lung Cancer Patients

Background: Advanced non-small cell lung cancer (NSCLC) has limited curative options and poor survival. Racotumomab, an anti-idiotype monoclonal antibody vaccine targeting tumor gangliosides, has shown efficacy in clinical trials. This study evaluated its real-world effectiveness as maintenance ther...

Whakaahuatanga katoa

I tiakina i:
Ngā kaituhi matua: Sailyn Alfonso Alemán, Haslen Cáceres Lavernia, Kirenia Camacho Sosa, Soraida C. Acosta Brooks, Orestes Santos Morales, Carmen E. Viada González, Meylán Cepeda Portales, Mayelín Troche Concepción, Loipa Medel Pérez, Leticia Cabrera Benítez, Milagros C. Domecq Salmón, Daymys Estévez Iglesias, Mayra Ramos Suzarte, Tania Crombet Ramos
Hōputu: Artigo
Reo:Inglês
I whakaputaina: MDPI AG 2025-10-01
Rangatū:Vaccines
Ngā marau:
anti-idiotypic vaccine
racotumomab
NSCLC
cancer vaccine
real world data
Urunga tuihono:https://www.mdpi.com/2076-393X/13/10/1035
Ngā Tūtohu: Tāpirihia he Tūtohu
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!

Ngā tūemi rite